Skip to main content
. 2017 Aug 15;2017(8):CD007476. doi: 10.1002/14651858.CD007476.pub3

7.11. Analysis.

7.11

Comparison 7 Transfusion‐dependent thalassemia: deferasirox + deferiprone vs deferiprone + deferoxamine, Outcome 11 Non‐related drug AEs (# participants affected).